상세 보기
A Response to the Letter to the Editor: "Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps"
- Lee, Se-Hoon;
- Lu, Shun;
- Yang, James Chih-Hsin;
- Shah, Sujay;
- Sethi, Seema;
- 외 1명
Citations
WEB OF SCIENCE
0Citations
SCOPUS
0- 제목
- A Response to the Letter to the Editor: "Lazertinib Versus Osimertinib in EGFR-Mutant NSCLC: Efficacy, Toxicity, and Unaddressed Clinical Gaps"
- 저자
- Lee, Se-Hoon; Lu, Shun; Yang, James Chih-Hsin; Shah, Sujay; Sethi, Seema; Cho, Byoung Chul
- 발행일
- 2026-01
- 유형
- Letter
- 권
- 21
- 호
- 1
- 페이지
- 199 ~ 200